News
December 13, 2024

IU announces $138 million Lilly Endowment grant, launches partnership to accelerate bioscience innovation

Regenstrief one of the partners expected to drive advancements and commercialization in biosciences 

Regenstrief Institute will partner with Indiana University and other key bioscience organizations in the state to make significant advances in human health and help make Indiana a global leader in bioscience innovation by establishing the IU Launch Accelerator for Biosciences, known as IU LAB, at the 16 Tech Innovation District in Indianapolis. 

“IU LAB will play a critical role in advancing life and biosciences innovation to address our state’s most critical health challenges,” said Rachel Patzer, PhD, MPH, Regenstrief president and CEO. Through its efforts to translate research into practice, this partnership will lead to better health outcomes and improved health care across Indiana.”  

View the complete press release on Indiana University’s webpage 

Partners

Related News

Regenstrief researcher Jiang Bian named Fellow of ACTS inaugural cohort

Jiang Bian, PhD, of the Regenstrief Institute has been named a 2026 Fellow of the Association for Clinical and Translational Science (ACTS),

Primary Care and Survival: Implications for Research and Policy

Published in the Journal of General Internal Medicine. Here is a link to the article.   Regenstrief Institute authors: David Haggstrom, M.D.,

Regenstrief researcher awarded American Geriatrics Society fellowship

Regenstrief Institute Research Scientist Noll Campbell, PharmD, M.S., has been named one of 11 physicians, pharmacists, researchers and healthcare leaders nationwide